Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.33 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29411228 | 0.84 | SLC6A5 (0.45) | SLC6A5DPP8DPP9DPP7 | |
| SCHEMBL7175771 | 0.82 | NOD1 (0.49) | NOD1SLC6A5CHRM1AKR1A1CHRM3 | |
| SCHEMBL7175773 | 0.82 | NOD1 (0.49) | NOD1SLC6A5CHRM1AKR1A1CHRM3 | |
| SCHEMBL23792690 | 0.82 | NOD1 (0.34) | NOD1SLC6A5DNM1HDAC7HDAC8 | |
| SCHEMBL25474281 | 0.78 | CTSS (0.34) | NOD1SLC6A5DNM1HDAC7HDAC8 | |
| SCHEMBL13048990 | 0.74 | CTSK (0.40) | HDAC7HDAC8HDAC6HDAC9HDAC5 | |
| SCHEMBL12175194 | 0.74 | CTSK (0.40) | HDAC7HDAC8HDAC6HDAC9HDAC5 | |
| SCHEMBL18438966 | 0.74 | CTSK (0.43) | L3MBTL1CYP2C9TDP1POLBKMT2A | |
| SCHEMBL18438964 | 0.74 | CTSK (0.43) | L3MBTL1CYP2C9TDP1POLBKMT2A | |
| SCHEMBL24235744 | 0.74 | POLB (0.51) | DNM1L3MBTL1POLBKMT2AACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159594-A1 | COMPOUNDS FOR USE IN VIRAL INFECTIONS | PHARMA MAR, S.A. (ES) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159594-A1 | COMPOUNDS FOR USE IN VIRAL INFECTIONS | OAT, MAVS, HAVCR2 | NOD1 3325/4885SLC6A5 3489/4885DNM1 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.